Causal relationships between gut microbiota, metabolites, and chronic kidney disease: a two-step, two-sample Mendelian randomization study

Clicks: 7
ID: 325242
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #41 of 129 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 129 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Chronic kidney disease (CKD) is a major global health concern with a multifactorial pathogenesis. Emerging evidence suggests that the gut microbiota and its metabolic products contribute to CKD development. However, robust evidence supporting metabolites as causal mediators in this pathway remains limited. We aimed to investigate causal relationships and mediating effects linking gut microbiota, circulating metabolites, and CKD. Methods Two-sample Mendelian randomization (MR) analyses were conducted using summary statistics from large-scale genome-wide association studies (GWAS) on gut microbiota, plasma metabolites, and CKD-related outcomes. Independent single-nucleotide polymorphisms strongly associated with each exposure were selected as instrumental variables. The inverse-variance weighted method served as the primary analysis, complemented by four additional MR approaches. Heterogeneity and pleiotropy were assessed using Cochran’s Q test, the MR-Egger intercept, and MR-PRESSO. Mediation analysis quantified the proportion of microbiota–CKD effects mediated by specific metabolites. Results MR analyses identified causal associations among multiple gut microbial pathways, circulating metabolites, and CKD-related traits. Mediation analysis revealed that argininate partially mediated the effect of the microbial pathway PWY-6629 on the urinary albumin-to-creatinine ratio (UACR), accounting for 22% of the total effect. A one–standard-deviation increase in genetically predicted PWY-6629 activity was associated with a 1.3% increase in UACR, mediated through a 7.9% reduction in argininate levels. Conversely, higher genetically predicted argininate levels were associated with a 3.7% reduction in UACR. Conclusion This study provides genetic evidence that gut microbiota influence CKD risk partially through circulating metabolites, highlighting the gut microbiota–metabolite–CKD axis as a potential therapeutic target.
Reference Key
openalex_W7203675715 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yingzhe Qian, Yue Yang, Ziyan Shen, Han Zhang, Jing Chen, Cheng Zhu, Jie Teng, Xiaogang Du
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag263
URL
https://doi.org/10.1093/ckj/sfag263
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.